President and CEO Hiroshi Nomura PLAY LIST from the beginning Investors Meeting Presentation for Q2 FY2018 (April 1 to September 30, 2018) Disclaimer Regarding Forward-looking Statements Financial Results for Q2 FY2018 Financial Results for Q2 FY2018 (Core Basis) Revenue of Major Products in Japan Revenue of Major Products in North America & China Segment Information (Core Basis) Financial Results for Q2 FY2018 (Full Basis) Financial Forecasts for FY2018 Financial Forecasts for FY2018 (Core Basis) Revenue of Major Products in Japan Revenue of Major Products in North America & China Segment Information (Core Basis) Major Topics (North America & Japan Business) Status of LATUDA ANDA litigations TRx Growth of LATUDA Activities of Japan Business Unit Research and Development Progress of Focus Research Areas & Frontier area (1) Progress of Focus Research Areas & Frontier area (2) Activities in FY2018 : Clinical Development Status Development Pipeline (as of October 2018) Product Launch Target (as of October 2018) Appendices Adjustments to Core Operating Profit Financial Position / Cash Flows Regenerative Medicine/Cell Therapy Business Plan (as of October 2018) @ Q&A Q&A 1 Q&A 2 Q&A 3 Q&A 4 Q&A 5 Q&A 6 Q&A 7 Q&A 8 Back Next